Fundamentals of cancer pain management

Supportive Cancer Care

Volumn , Issue , 2016, Pages 111-126

  Smith, Thomas J ^a,b,c   O'Neil, Joe ^d  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Departments of Orthopaedic Surgery and Oncology   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85026712154     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-24814-1_7     Document Type: Chapter

References (69)

1. Cohen MZ, Pace EA, Kaur G, Bruera E. Delirium in advanced cancer leading to distress in patients and family caregivers. J Palliat Care. 2009;25(3):164-71.
2. van den Beuken-van Everdingen M, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18(9):1437-49.
3. Fisch MJ, Lee JW, Weiss M, et al. Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol. 2012;30(16):1980-8.
4. Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994;330(9):592-6.
5. Drageset J, Corbett A, Selbaek G, Husebo BS. Cancer-related pain and symptoms among nursing home residents: a systematic review. J Pain Symptom Manage. 2014;48:699-710.e1.
6. Farmer P, Frenk J, Knaul FM, et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet. 2002;376(9747):1186-93.
7. World Health Organization. Cancer. World Health Organization N*297. 2014. Ref Type: Online Source http://www.who.int/medicines/areas/quality_safety/guide_nocp_sanend/en/
8. World Health Organization. Ensuring balance in national policies on controlled substances. 2014. Ref Type: Online Source http://www.who.int/medicines/areas/quality_safety/guide_nocp_sanend/en/
9. Pachman DR, Barton DL, Swetz KM, Loprinzi CL. Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. J Clin Oncol. 2012;30(30):3687-96.
10. Stockler MR, Wilcken NRC. Why is management of cancer pain still a problem? J Clin Oncol. 2012;30(16):1907-8.
11. Richmond C. Dame Cicely Saunders. BMJ. 2005;331:238.
12. Mercadante S. Managing difficult pain conditions in the cancer patient. Curr Pain Headache Rep. 2014;18(2):395.
13. Merskey H, Bogduk N. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms, Task Force on Taxonomy of the IASP. 2nd ed. Seattle: IASP Press; 1994.
14. Fink J. The pathophysiology of acute pain. Emerg Med Clin North Am. 2005;23(2):277-84.
15. Schmidt B, et al. Mechanism of cancer pain. Schmidt BL1, Hamamoto DT, Simone DA, Wilcox GL. Mol Interv. 2010;10(3):164-78. doi:10.1124/mi.10.3.7.
16. Ossipov MH. The perception and endogenous modulation of pain. Scientifica. 2012;561761:1-25. doi:10.6064/2012/561761.
17. Gregory NS, Harris AL, Robinson CR, Dougherty PM, Fuchs PN, Sluka KA. An overview of animal models of pain: disease models and outcome measures. J Pain. 2013;14(11):1255-69.
18. Cohen SPM. Neuropathic pain: mechanisms and their clinical implications. BMJ. 2014;348:f7656.
19. Kerstman E, Ahn S, Battu S, Tariq S, Grabois M. Chapter 15 - Neuropathic pain. In: Michael PBaD, editor. Handbook of clinical neurology neurological rehabilitation. 110th ed. Elsevier, Amsterdam; 2013. p. 175-87.
20. Giordano J, Abramson K, Boswell M. Pain assessment: subjectivity, objectivity, and the use of neurotechnology. Pain Physician. 2010;13(4):305-15.
21. Cook K, Dunn W, Griffith JW, et al. Pain assessment using the NIH Toolbox. Neurology. 2013;80(11 Suppl 3):S49-53.
22. Hjermstad M, Fainsinger R, Kaasa S. Assessment and classification of cancer pain. Curr Opin Support Palliat Care. 2009;3(1):24-30.
23. Cocksedge S, George B, Renwick S, Chew-Graham C. Touch in primary care consultations: qualitative investigation of doctors' and patients' perceptions. Br J Gen Pract. 2013;63(609):e283-90.
24. Mercadante S, Fulfaro F. World Health Organization guidelines for cancer pain: a reappraisal. Ann Oncol. 2005;16 suppl 4:iv132-5.
25. Vargas-Schaffer G. Is the WHO analgesic ladder still valid?: Twenty-four years of experience. Can Fam Physician. 2010;56(6):514-7.
26. Mercadante S, Villari P, Ferrera P, Casuccio A. Optimization of opioid therapy for preventing incident pain associated with bone metastases. J Pain Symptom Manage. 2004;28(5):505-10.
27. Mercadante S, Villari P, Ferrera P, Arcuri E, David F. Opioid switching and burst ketamine to improve the opioid response in patients with movement-related pain due to bone metastases. Clin J Pain. 2009;25(7):648-9.
28. Pathan H, Williams J. Basic opioid pharmacology: an update. Br J Pain. 2012;6(1):11-6.
29. National Cancer Institutes of Health. Highlights of patient management current clinical trials. National Cancer Institute; 2014.
30. Hanks GW, Fd C, Cherny N, et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer. 2001;84(5):587.
31. Archimedes, Various Newswires. Lazanda (fentanyl citrate) nasal spray. CenterWatch 2011. https://www.centerwatch.com/drug-information/fda-approved-drugs/drug/1159/lazanda-fentanyl-citrate-nasal-spray
32. Smith T, Coyne PJ, Staats PS, et al. An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM). Ann Oncol. 2005;16(5):825-33.
33. Bruera E, Palmer JL, Bosnjak S, et al. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study. J Clin Oncol. 2004;22(1):185-92.
34. Heiskanen T, Mäñtzke S, Haakana S, Gergov M, Vuori E, Kalso E. Transdermal fentanyl in cachectic cancer patients. Pain. 2009;144(1GÇô2):218-22.
35. Tarumi Y, Wilson MP, Szafran O, Spooner GR. Randomized, double-blind, placebo-controlled trial of oral docusate in the management of constipation in hospice patients. J Pain Symptom Manage. 2013;45(1):2-13.
36. Division of Drug Information. Investigational New Drug Application Domperidone. 2015. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/InvestigationalNewDrugINDApplication/ucm368736.htm
37. Esin E, Yalcin S. Neuropathic cancer pain: what we are dealing with? How to manage it? Onco Targets Ther. 2014;7:599-618.
38. Eisenberg E, Berkey CS, Carr DB, Mosteller F, Challmers TC. Efficacy and safety of nonsteroidal antiinflammatory drugs for cancer pain: a meta-analysis. J Clin Oncol. 1994;12(12):2756-65.
39. Berna C, Leknes S, Holmes EA, Edwards RR, Goodwin GM, Tracey I. Induction of depressed mood disrupts emotion regulation neurocircuitry and enhances pain unpleasantness. Biol Psychiatry. 2010;67(11):1083-90.
40. Imani F, Rahimzadeh P. Gabapentinoids: gabapentin and pregabalin for postoperative pain management. Anesth Pain Med. 2012;2(2):52-3.
41. Paulsen Ø, Aass N, Kaasa S, Dale O. Do corticosteroids provide analgesic effects in cancer patients? A systematic literature review. J Pain Symptom Manage. 2013;46(1):96-105.
42. Bruera E, Moyano JR, Sala R, et al. Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a randomized controlled trial. J Pain Symptom Manage. 2004;28(4):381-8.
43. Yennurajalingam S, Frisbee-Hume S, Palmer JL, et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol. 2013;31(25):3076-82.
44. Lopez-olivo MA, Shah NA, Pratt G, Risser JM, Symanski E, Suarez-almazor ME. Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis. Support Care Cancer. 2012;20(11):2985-98.
45. Martinez-Zapata M, Figuls M, Alonso-Coello P, Roman Y, Catala E. Calcitonin for mestastic bone pain. The Cochrane Library. 2006;(3):CD003223.
46. Cai B, Nickman NA, Gaffney DK. The role of palliative external beam radiation therapy in boney metastases pain management. J Pain Palliat Care Pharmacother. 2013;27(1):28-34.
47. Sartor O, Coleman R, Nilsson S, et al. Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial. Lancet Oncol. 2014;15(7):738-46.
48. Parker C, Nilsson S, Heinrich D, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013;369(3):213-23.
49. Soriano A, Davis MP. Malignant bowel obstruction: individualized treatment near the end of life. Cleve Clin J Med. 2011;78(3):197-206.
50. Deer TR, Krames E, Mekhail N, et al. The appropriate use of neurostimulation: new and evolving neurostimulation therapies and applicable treatment for chronic pain and selected disease states. Neuromodulation. 2014;17(6):599-615.
51. Al-Jehani H, Jacques L. Peripheral nerve stimulation for chronic neurogenic pain. Prog Neurol Surg. 2011;2011(24):24-400.
52. Marineo G. Untreatable pain resulting from abdominal cancer: new hope from biophysics? JOP. 2003;4(1):1-10.
53. Ricci M, Pirotti S, Scarpi E, et al. Managing chronic pain: results from an open-label study using MC5-A Calmare-« device. Support Care Cancer. 2014;20(2):405-12.
54. Smith TJ, Coyne PJ, Parker GL, Dodson P, Ramakrishnan V. Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-A Calmare®) for chemotherapy-induced peripheral neuropathy. J Pain Symptom Manage. 2010;40(6):883-91.
55. Marineo G, Iorno V, Gandini C, Moschini V, Smith TJ. Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management: results of a pilot, randomized, controlled trial. J Pain Symptom Manage. 2012;43(1):87-95.
56. Swislocki A, Orth M, Bales M, et al. A randomized clinical trial of the effectiveness of photon stimulation on pain, sensation, and quality of life in patients with diabetic peripheral neuropathy. J Pain Symptom Manage. 2010;39(1):88-99.
57. Fortino V, Pelaez D, Cheung H. Concise review: stems cell therapies for neuropathic pain. Stem Cells Transl Med. 2013;2(5):394-9.
58. Salata K, Kowalczykb P, Gryzlob B, Jakubowskab A, Kulig K. New investigational drugs for the treatment of neuropathic pain. Expert Opinion on Investigational Drugs. 2014;23(8):1093-1104. doi:10.1517/13543784.2014.916688.
59. Schumacher KL, Plano Clark VL, West CM, Dodd MJ, Rabow MW, Miaskowski C. Pain medication management processes used by oncology outpatients and family caregivers part I: health systems contexts. J Pain Symptom Manage. 2014;48:770-83.
60. Miaskowski C, Dodd M, West C, et al. Randomized clinical trial of the effectiveness of a selfcare intervention to improve cancer pain management. J Clin Oncol. 2004;22(9):1713-20.
61. Koller A, Miaskowski C, De Geest S, Opitz O, Spichiger E. Results of a randomized controlled pilot study of a self-management intervention for cancer pain. Eur J Oncol Nurs. 2013;17(3):284-91.
62. Rustoen T, Valeberg B, Kolstad E, Wist E, Paul S, Miaskowski C. A randomized clinical trial of the efficacy of a self-care intervention to improve cancer pain management. Cancer Nurs. 2013;37(1):34-43.
63. Parikh RB, Kirch RA, Smith TJ, Temel JS. Early specialty palliative care GÇö translating data in oncology into practice. N Engl J Med. 2013;369(24):2347-51.
64. Smith TJ, Temin S, Alesi ER, et al. American society of clinical oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol. 2012;30(8):880-7.
65. WHO Executive Board, 134th session EB134.R7, Agenda item 9.4 23 January 2014. Strengthening of palliative care as a component of integrated treatment within the continuum of care. Meeting Minutes.
66. Sullivan A, Warren A, Lakoma M, Liaw K, Hwang D, Block S. End-of-life care in the curriculum: A National Study of Medical Education Deans. OvidSP. 2004;79(8):760-8. Ref Type: Abstract.
67. Making the case for hospital-based palliative care. CAPC. 2014. https://www.capc.org/topics/hospital/, accessed October 27, 2015.
68. Morrison RS, Penrod JD, Cassel JB, et al. Palliative Care Leadership Centers' Outcomes Group. Cost savings associated with US hospital palliative care consultation programs. Arch Intern Med. 2008;168(16):1783.
69. Parikh RB, Kirch RA, Smith TJ, Temel JS. Early specialty palliative care - translating data in oncology into practice and policy. N Engl J Med. 2013;69:2347-51.